BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

FIRST MANHATTAN CO. LLC.'s Holding History (CIK: 0000728083)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023

Shares 874,840 Value ($000) $6,194 Avg Close $7.18 Range $6.62 - $7.95

Q2 2023

Shares 874,840 Value ($000) $6,159 Avg Close $8.02 Range $6.87 - $9.07

Q1 2023

Shares 874,840 Value ($000) $7,296 Avg Close $9.63 Range $7.82 - $12.08

Q4 2022

Shares 1,868,672 Value ($000) $21,452 Avg Close $12.47 Range $10.36 - $14.50

Q3 2022

Shares 1,805,072 Value ($000) $22,743 Avg Close $12.87 Range $10.33 - $15.43

Q2 2022

Shares 1,805,072 Value ($000) $19,097 Avg Close $10.32 Range $7.61 - $18.00

Q3 2015

Shares 5,000 Value ($000) $57 Avg Close $13.34 Range $10.26 - $16.83

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2023	874,840	$6,194	$7.18	$6.62 - $7.95
Q2 2023	874,840	$6,159	$8.02	$6.87 - $9.07
Q1 2023	874,840	$7,296	$9.63	$7.82 - $12.08
Q4 2022	1,868,672	$21,452	$12.47	$10.36 - $14.50
Q3 2022	1,805,072	$22,743	$12.87	$10.33 - $15.43
Q2 2022	1,805,072	$19,097	$10.32	$7.61 - $18.00
Q3 2015	5,000	$57	$13.34	$10.26 - $16.83